| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 470* | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ... Medrxiv, 2021 | 298 | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 218 | 2022 |
| Inflammatory phenotyping predicts clinical outcome in COVID-19 H Burke, A Freeman, DC Cellura, BL Stuart, NJ Brendish, S Poole, ... Respiratory research 21, 1-9, 2020 | 79 | 2020 |
| Serum 25-dihydroxyvitamin D levels correlate with CD4+ Foxp3+ T-cell numbers in moderate/severe asthma ES Chambers, AM Nanzer, DF Richards, K Ryanna, AT Freeman, ... Journal of Allergy and Clinical Immunology 130 (2), 542-544, 2012 | 75 | 2012 |
| Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre AA Sivaloganathan, M Nasim-Mohi, MM Brown, N Abdul, A Jackson, ... British journal of anaesthesia 125 (4), e368-e371, 2020 | 69 | 2020 |
| Dynamics of IFN-â responses during respiratory viral infection. Insights for therapeutic strategies A Watson, CM Spalluto, C McCrae, D Cellura, H Burke, D Cunoosamy, ... American journal of respiratory and critical care medicine 201 (1), 83-94, 2020 | 64 | 2020 |
| Using novel computed tomography analysis to describe the contribution and distribution of emphysema and small airways disease in chronic obstructive pulmonary disease K Ostridge, K Gove, KHW Paas, H Burke, A Freeman, S Harden, M Kirby, ... Annals of the American Thoracic Society 16 (8), 990-997, 2019 | 44 | 2019 |
| The effects of calcitriol treatment in glucocorticoid-resistant asthma AM Nanzer, ES Chambers, K Ryanna, AT Freeman, G Colligan, ... Journal of Allergy and Clinical Immunology 133 (6), 1755-1757. e4, 2014 | 43 | 2014 |
| Clinical evaluation of type 2 disease status in a real‐world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts A Azim, C Newell, C Barber, M Harvey, D Knight, A Freeman, WCG Fong, ... Clinical & Experimental Allergy 51 (6), 811-820, 2021 | 34 | 2021 |
| New perspectives on difficult asthma; sex and age of asthma-onset based phenotypes A Azim, A Freeman, A Lavenu, H Mistry, HM Haitchi, C Newell, Y Cheng, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (10), 3396 …, 2020 | 31 | 2020 |
| Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19 TJM Wallis, E Heiden, J Horno, B Welham, H Burke, A Freeman, L Dexter, ... Respiratory research 22 (1), 157, 2021 | 29 | 2021 |
| Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic A Azim, H Mistry, A Freeman, C Barber, C Newell, K Gove, Y Thirlwall, ... BMC Pulmonary Medicine 19, 1-11, 2019 | 28 | 2019 |
| Real‐world omalizumab and mepolizumab treated difficult asthma phenotypes and their clinical outcomes WCG Fong, A Azim, D Knight, H Mistry, A Freeman, M Felongco, A Kyyaly, ... Clinical & Experimental Allergy 51 (8), 1019-1032, 2021 | 25 | 2021 |
| Dysregulation of COVID-19 related gene expression in the COPD lung A Watson, L Öberg, B Angermann, CM Spalluto, M Hühn, H Burke, ... Respiratory research 22 (1), 164, 2021 | 25 | 2021 |
| Defining a role for exercise training in the management of asthma AT Freeman, KJ Staples, TMA Wilkinson European Respiratory Review 29 (156), 2020 | 25 | 2020 |
| Azithromycin in hospitalised patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, A Roddick, E Spata, N Staplin, JR Emberson, ... MedRxiv, 2020.12. 10.20245944, 2020 | 22 | 2020 |
| Patient perceived barriers to exercise and their clinical associations in difficult asthma AT Freeman, D Hill, C Newell, H Moyses, A Azim, D Knight, L Presland, ... Asthma research and practice 6, 1-11, 2020 | 19 | 2020 |
| Barriers to implementing a policy not to attempt resuscitation in acute medical admissions: prospective, cross sectional study of a successive cohort. WJ Fidler H1, Thompson C, Freeman A, Hogan D, Walker G BMJ 25 (332 (7539)), 461-2, 2006 | 17* | 2006 |
